Biostax Corp. BTAX
0.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.0002
- YTD
- +100.00%
- 1 year
- +100.00%
News
globenewswire.com Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies,…
globenewswire.com Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception Orlando, FL, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Biostax Corp ., (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, proudly announces its participation in the upcoming U.S.…
globenewswire.com Biostax Announces a Director Appointment of Influential Business Leader Craig Suro Orlando, FL, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the appointment of Influential Business Leader Roger…
globenewswire.com Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors Orlando, FL, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the appointment of Ms. Clay Caperton to its Board of…
globenewswire.com Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a milestone in its transformative…